Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy Podcast Por  arte de portada

Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy

Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy

Escúchala gratis

Ver detalles del espectáculo

Obtén 3 meses por US$0.99 al mes

Interview with Ehsan Rahimy, MD, author of Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy. Hosted by Neil Bressler, MD.

Related Content:

  • Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy
Todavía no hay opiniones